AMJ

04/06/2026

Scientists are still searching for reliable biomarkers in lupus nephritis.

Most proposed markers lack strong evidence - with only a few showing real promise.

Read more:

Lupus nephritis biomarkers show promise, but most lack strong evidence for clinical use. Read more on key findings.

04/05/2026

New data suggests that achieving a pathologic complete response in the lymph nodes doesn't always mean the breast is clear of cancer.

In a study of patients with biopsy-proven nodal disease, nearly 42% still had residual disease in the breast despite their nodes testing clear after chemotherapy.

Learn more:

Regional nodal irradiation may not affect 5 year DFS after nodal pCR with residual breast disease. Read more.

04/04/2026

A new analysis confirms that structured interventions, especially cognitive behavioral therapy, significantly reduces anxiety and depression for parents in pediatric palliative care.

link emoji pls:

Psychological interventions may reduce parent distress in pediatric palliative care, especially short term. Read more.

04/03/2026

Designing effective mRNA cancer vaccines is a massive data challenge: most predicted targets never actually trigger an immune response.

New research highlights how AI is revolutionizing this process by mapping the ""tumor immunity landscape"" to filter out false positives moving us closer to truly personalized immunotherapy that actually works in the complex environment of a solid tumor.

Explore more: https://hubs.la/Q049pt9k0

04/02/2026

Meningitis can progress rapidly.

With a recent UK outbreak, knowing the signs matters: fever, chills, and a rash that doesn’t fade under pressure.

Early action and vaccination are key.

Learn more: https://hubs.la/Q049sDqW0

04/02/2026

Are safety concerns impacting treatment decisions in relapsing MS?

In conversation with AMJ, Dr Robert Shin addresses common concerns that limit safety confidence and reduce treatment utilization, and discusses how timing and therapy selection may relate to disease progression in relapsing MS.

Dive into the long-term safety data for an S1P receptor modulator and decide for yourself.

Read more: https://hubs.la/Q049rnTF0



This content is sponsored by Bristol Myers Squibb and is intended for US neurologists only.

04/02/2026

Is poor judgment an early warning sign of cognitive decline?

New research suggests that a decline in practical judgment, the ability to evaluate information and anticipate consequences, often emerges well before a dementia diagnosis. The study found that older adults with mild cognitive impairment are significantly more vulnerable to scams and social exploitation.

For clinicians and families, tracking real-world decision making can be a vital red flag for early cognitive changes.

Read more: https://hubs.la/Q049ps6Y0

04/02/2026

Could microneedle patches be the end of stubborn hyperpigmentation?

Traditional creams often fail to reach the deeper skin layers where excess melanin lives, but new research highlights dissolving microneedle patches as a game-changer for hyperpigmentation.

By bypassing the skin’s outer barrier, these patches deliver active ingredients like niacinamide directly to the source.

Learn more: https://hubs.la/Q049psQT0

04/01/2026

Sleep apnea could be a hidden comorbidity in lung cancer.

New research shows that obstructive sleep apnea affects nearly 50% of never-smokers newly diagnosed with lung cancer. Surprisingly, this remains true even in patients with a healthy BMI.

https://hubs.la/Q049grHq0

04/01/2026

update: Remibrutinib improves itch and hives in chronic spontaneous urticaria within 12 hours.

Learn more:

Remibrutinib improved itch and hives within 12 hours in CSU. Read more.

03/31/2026

Scientists have developed a new highly accurate blood test that can detect missed endometriosis cases.

Explore here: https://hubs.la/Q0493Dn-0

03/29/2026

Fractional CO2 vs. microneedling radiofrequency: which is better for acne scars?

New data from 249 patients confirms:

CO2 laser could deliver higher efficacy and patient satisfaction, but significantly more pain, longer downtime, and higher hyperpigmentation risk.

The study emphasizes that the best depends on your patient's goals, is it maximum results or a safer, faster recovery?

Full study details here: https://hubs.la/Q048H4-V0